The goal of the proposed research is the characterization of the innervation to the anterior segment of the eye by histochemical and biochemical means, placing greatest emphasis in the following areas. We will describe the nerves containing a variety of biologically active peptides using immunohistochemical techniques. With these techniques and other selected methods, we plan to continue to search for other neurohumors as yet undescribed in the anterior segment, with emphasis on biologically active peptides and biogenic amines. Although most work will be performed in laboratory animals, the studies will be extended to human eyes, particularly for characterization of the peptidergic innervation. To identify precisely the origin of specific nerve types, proposed studies include evaluation of ocular tissues after selective denervation, careful analysis of all autonomic ganglia serving the eye, and examination of these ganglia after injection into the anterior chamber of tracers of retrograde axoplasmic transport. We also seek to define the interrelationship of the various neurohumors in the peripheral innervation of the eye. To seek evidence for the coexistence of neurohumors in the nerves to the anterior segment, neuro-anatomical studies are proposed that will combine several techniques such as immunohistochemistry and retrograde axonal transport. Biochemical isolation and characterization of selected neurohumors is proposed as an important complement to the immunohistochemical methodology. Through these studies we seek to define in comprehensive detail the innervation of the anterior segment of the eye. Through the coordination of anatomical, histochemical, and biochemical studies, information will be derived necessary to understand the neural control mechanisms governing ocular physiology. These studies likely will lead to an improved understanding of the pathophysiology of important ocular diseases, most notably glaucoma and certain forms of inflammation. Furthermore, because of the importance of neural mechanisms in ocular pharmacology, these studies may well lead to new drug therapies.

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Research Project (R01)
Project #
5R01EY005454-02
Application #
3260523
Study Section
Visual Sciences A Study Section (VISA)
Project Start
1984-07-01
Project End
1989-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
2
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Grimes, P A; Lahiri, S; Stone, R et al. (1994) Nitric oxide synthase occurs in neurons and nerve fibers of the carotid body. Adv Exp Med Biol 360:221-4
Grimes, P A; McGlinn, A M; Koeberlein, B et al. (1994) Galanin immunoreactivity in autonomic innervation of the cat eye. J Comp Neurol 348:234-43
Yamamoto, R; Bredt, D S; Dawson, T M et al. (1993) Enhanced expression of nitric oxide synthase by rat retina following pterygopalatine parasympathetic denervation. Brain Res 631:83-8
Li, H; Grimes, P (1993) Adrenergic innervation of the choroid and iris in diabetic rats. Curr Eye Res 12:89-94
Lin, T; Grimes, P A; Stone, R A (1993) Expansion of the retinal pigment epithelium in experimental myopia. Vision Res 33:1881-5
Yamamoto, R; Bredt, D S; Snyder, S H et al. (1993) The localization of nitric oxide synthase in the rat eye and related cranial ganglia. Neuroscience 54:189-200
Yamamoto, R; McGlinn, A; Stone, R A (1991) Brain natriuretic peptide-immunoreactive nerves in the porcine eye. Neurosci Lett 122:151-3
Iuvone, P M; Tigges, M; Stone, R A et al. (1991) Effects of apomorphine, a dopamine receptor agonist, on ocular refraction and axial elongation in a primate model of myopia. Invest Ophthalmol Vis Sci 32:1674-7
Stone, R A; Lin, T; Laties, A M (1991) Muscarinic antagonist effects on experimental chick myopia. Exp Eye Res 52:755-8
Ye, X D; Laties, A M; Stone, R A (1990) Peptidergic innervation of the retinal vasculature and optic nerve head. Invest Ophthalmol Vis Sci 31:1731-7

Showing the most recent 10 out of 36 publications